BLUA.U: BlueRiver Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-third of a Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 0.00
Enterprise Value ($M) 0.78
Book Value ($M) -5.71
Book Value / Share -0.65
Price / Book 0.00
NCAV ($M) -25.89
NCAV / Share -2.97
Price / NCAV 0.00

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.25
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.01
Current Ratio 0.01

Balance Sheet (mrq) ($M)
Current Assets 0.04
Assets 20.22
Liabilities 25.93
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -7.51
Net Income -5.28

Cash Flow Statement (mra) ($M)
Cash From Operations -0.70
Cash from Investing 273.41
Cash from Financing -272.69

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal period ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SEC
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S
2023-05-16 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)

Similar Companies
BAX – Baxter International Inc. BDX – Becton, Dickinson and Company
BFLY – Butterfly Network, Inc. BSX – Boston Scientific Corporation
CDRE – Cadre Holdings, Inc.


Financial data and stock pages provided by
Fintel.io